These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

45 related articles for article (PubMed ID: 5734901)

  • 1. [Origin of dopaminergic and serotoninergic striatal afferent currents in cats].
    Bédard P; Larochelle L; Poirier LJ
    J Physiol (Paris); 1968; 60 Suppl 2():345. PubMed ID: 5734901
    [No Abstract]   [Full Text] [Related]  

  • 2. Thalamic regulation of striatal acetylcholine efflux is both direct and indirect and qualitatively altered in the dopamine-depleted striatum.
    Zackheim J; Abercrombie ED
    Neuroscience; 2005; 131(2):423-36. PubMed ID: 15708484
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Regulation of release processes in central serotoninergic neurons.
    Héry F; Ternaux JP
    J Physiol (Paris); 1981; 77(2-3):287-301. PubMed ID: 6457140
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Distribution of the dopamine innervation in the macaque and human thalamus.
    García-Cabezas MA; Rico B; Sánchez-González MA; Cavada C
    Neuroimage; 2007 Feb; 34(3):965-84. PubMed ID: 17140815
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of 17-beta-estradiol on dopamine, serotonine and GABA striatal levels in 6-hydroxydopamine-treated rats.
    Peinado V; González JC; Leret ML
    Toxicology; 2004 Nov; 204(2-3):155-60. PubMed ID: 15388241
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serotonergic hyperinnervation into the dopaminergic denervated striatum compensates for dopamine conversion from exogenously administered l-DOPA.
    Maeda T; Nagata K; Yoshida Y; Kannari K
    Brain Res; 2005 Jun; 1046(1-2):230-3. PubMed ID: 15894297
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Correlation of dopamine and serotoninergic components in the neurochemical organization of the emetic mechanism].
    Nalótov SV; Dolzhenko AT; Komisarov IV; Talalaienko OM; Kharin MO
    Fiziol Zh (1994); 1994; 40(1):10-4. PubMed ID: 7713217
    [TBL] [Abstract][Full Text] [Related]  

  • 8. S 16924 ((R)-2-[1-[2-(2,3-dihydro-benzo[1,4] dioxin-5-Yloxy)-ethyl]-pyrrolidin-3yl]-1-(4-fluoro-phenyl)-ethanone), a novel, potential antipsychotic with marked serotonin (5-HT)1A agonist properties: I. Receptorial and neurochemical profile in comparison with clozapine and haloperidol.
    Millan MJ; Gobert A; Newman-Tancredi A; Audinot V; Lejeune F; Rivet JM; Cussac D; Nicolas JP; Muller O; Lavielle G
    J Pharmacol Exp Ther; 1998 Sep; 286(3):1341-55. PubMed ID: 9732398
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Links between temperamental dimensions and brain monoamines in the rat.
    Ray J; Hansen S; Waters N
    Behav Neurosci; 2006 Feb; 120(1):85-92. PubMed ID: 16492119
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Modulation of dopamine release by striatal 5-HT2C receptors.
    Alex KD; Yavanian GJ; McFarlane HG; Pluto CP; Pehek EA
    Synapse; 2005 Mar; 55(4):242-51. PubMed ID: 15668911
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serotonin control of central dopaminergic function: focus on in vivo microdialysis studies.
    Di Matteo V; Di Giovanni G; Pierucci M; Esposito E
    Prog Brain Res; 2008; 172():7-44. PubMed ID: 18772026
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Brain monoamine changes in chronic paranoid schizophrenia and their possible relation to increased dopamine receptor sensitivity.
    Farley IJ; Shannak KS; Hornykiewicz O
    Adv Biochem Psychopharmacol; 1980; 21():427-33. PubMed ID: 6155058
    [No Abstract]   [Full Text] [Related]  

  • 13. Interactions of dopamine D1 and D2 receptor antagonists with D-methamphetamine-induced hyperthermia and striatal dopamine and serotonin reductions.
    Broening HW; Morford LL; Vorhees CV
    Synapse; 2005 May; 56(2):84-93. PubMed ID: 15714503
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [A possible mechanism of participation of dopaminergic cells and striatal cholinergic interneurons in the conditioned selection of motor activity].
    Sil'kis IG
    Zh Vyssh Nerv Deiat Im I P Pavlova; 2004; 54(6):734-49. PubMed ID: 15658038
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dopamine and 5-HT uptake by synaptosomes after pretreatment with p-chlorophenylalanine.
    Pazdernik TL; Tuomisto J
    Med Biol; 1983; 61(5):264-7. PubMed ID: 6231436
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Some derivatives of 3-amino-2-oxazolidinone influencing neurotransmission of dopamine and serotonin.
    Chilmonczyk Z; Krzywda J; Cybulski J; Iskra-Jopa J
    Pharmazie; 1997 Feb; 52(2):152-7. PubMed ID: 9122275
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Intracerebroventricular administration of cholecystokinin inhibits the dopamine- and serotoninergic systems of the brain].
    Vasar EE; Otter MIa; Riago LK
    Fiziol Zh SSSR Im I M Sechenova; 1982 Sep; 68(9):1218-22. PubMed ID: 7173435
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [The thalamus: a dynamic door to perception].
    Cudeiro-Mazaira FJ; Rivadulla-Fernández JC
    Rev Neurol; 2002 Jan 16-31; 34(2):121-30. PubMed ID: 11988906
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Origin of serotoninergic afferents to the hypoglossal nucleus in the rat.
    Manaker S; Tischler LJ
    J Comp Neurol; 1993 Aug; 334(3):466-76. PubMed ID: 8376628
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Elevated serotonin is involved in hyperactivity but not in the paradoxical effect of amphetamine in mice neonatally lesioned with 6-hydroxydopamine.
    Avale ME; Nemirovsky SI; Raisman-Vozari R; Rubinstein M
    J Neurosci Res; 2004 Oct; 78(2):289-96. PubMed ID: 15378510
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.